Safety and efficacy of more than 8 years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

被引：0

作者：

Reiff, Andreas ^{[1
]}

Lovell, Daniel ^{[1
]}

Ilowite, Norman ^{[2
]}

Wallace, Carol ^{[3
]}

机构：

[1] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA

[2] Schneider Childrens Hosp, New Hyde Pk, NY USA

[3] Childrens Hosp & Reg Med Ctr, Seattle, WA USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2008年 / 58卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：AB107 / AB107

页数：1

共 50 条

[1] Safety of over 8 years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
Lovell, D. L.
Giannini, E. H.
Wallace, C. A.
Ilowite, N. T.
Reiff, A. O.
Chon, Y.
Lin, S.
Baumgarter, S. W.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 112 - 112
[2] Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
Lovell, Daniel J.
Reiff, Andreas
Ilowite, Norman T.
Wallace, Carol A.
Chon, Yun
Lin, Shao-Lee
Baumgartner, Scott W.
Giannini, Edward H.
[J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (05): : 1496 - 1504
[3] Global safety and efficacy of more than 5 years of etanercept therapy in rheumatoid arthritis
Lebwohl, M
Gottlieb, A
Wallis, W
Zitnik, R
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P142 - P142
[4] Safety and efficacy of over 8 years of continuous etanercept therapy in patients with rheumatoid arthritis in north america and Europe
Klareskog, L.
Moreland, L. W.
Cohen, S. B.
Kalden, J. R.
Wajdula, J.
Chon, Y.
Baumgartner, S. W.
Tsujis, W. H.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 326 - 326
[5] Global safety and efficacy of more than 5 years of etanercept (ENBREL®) therapy in rheumatoid arthritis.
Moreland, LW
Cohen, SB
Klareskog, L
Burge, DJ
[J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S125 - S125
[6] Global safety and efficacy of more than 5 years of etanercept (ENBREL®) therapy in rheumatoid arthritis.
Moreland, LW
Cohen, SB
Klareskog, L
Sanda, M
Wajdula, J
Burge, DJ
[J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S532 - S532
[7] Safety and efficacy of more than 4 years of adalimumab therapy in rheumatoid arthritis
Schiff, M
Kavanaugh, A
Weisman, M
Segurado, O
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P203 - P203
[8] Safety and efficacy of over 9 years of continuous etanercept therapy in patients with rheumatoid arthritis in North America and Europe
Klareskog, L.
Moreland, L. W.
Cohen, S. B.
Kalden, J. R.
Wajdula, J.
Chon, Y.
Lin, S.
Baumgarter, S. W.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 177 - 177
[9] The safety and efficacy of over seven years of continuous etanercept therapy in patients with rheumatoid arthritis in North America and Europe
Klareskog, L
Moreland, LW
Cohen, SB
Baumgartner, SW
Tindall, EA
Kalden, JR
Whitmore, JB
Tsuji, WH
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 410 - 410
[10] Etanercept Therapy in Rheumatoid Arthritis: Efficacy and Safety
Ilic, Tatjana
Milic, Biljana
Celic, Dejan
Vuckovic, Biljana
Mitic, Igor
[J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (7-8) : 495 - 502

← 1 2 3 4 5 →